Fact Sheet: EtO Sterilization Prevents Infection

Ethylene oxide sterilizes 20 billion medical devices in the United States each year. Sterilized equipment is critical to preventing serious, even life-threatening, infections in patients at the doctor and in the hospital every day.
Related Reading
News / Coverage & Payment / Diabetes / Government & Legislative Affairs / Health Access
AdvaMed Urges CMS to Fix “Serious Flaws” in Proposed Medicare Durable Medical Equipment Competitive Bidding Rule, Cites Concerns of Patient Safety, Fewer Treatment Options, Increased Costs if Rule Stands
August 28, 2025
WASHINGTON, D.C.—AdvaMed, the world’s largest trade association representing medtech innovators, today urged the Centers for Medicare and Medicaid Services (CMS) to fix “serious flaws” in its proposed rule to restart competitive bidding for durable medical equipment in Medicare, citing risks to patient safety, fewer product choices for beneficiaries, and cost increases that would result if the rule stands.
Blog / Code of Ethics / Compliance / Legal / Regulatory Affairs / The MedTech Conference
AdvaMed in Action: Legal, Compliance, and Regulatory in the Spotlight at The MedTech Conference 2025
August 27, 2025
Christopher L. White, Esq., AdvaMed’s General Counsel & Chief Policy Officer, on why this year’s legal, compliance & regulatory programming is mission-critical as medtech leaders navigate uncertainty, shifting enforcement priorities, and a rapidly changing global legal landscape.
Blog / Diabetes / Government & Legislative Affairs / Health Access
Smart Back-to-School Policy: Cell Phone Bans with a Medical Exception
August 21, 2025
Thousands of K-12 students returning to school this fall will face a cell phone use ban during instructional hours. Diabetes monitoring deserves an exception.
News / Coverage & Payment / Diagnostics / Digital Health / Government & Legislative Affairs / Health Access / Regulatory Affairs
AdvaMed, Patient Groups, State Medtech Associations Urge Medicare Coverage of Breakthrough Medtech
August 20, 2025
WASHINGTON, D.C.—AdvaMed, the Medtech Association, is among 67 stakeholder groups, including patient advocacy groups and state medtech and life sciences associations, urging the Centers for Medicare and Medicaid Services (CMS) to create a timely, streamlined pathway for Medicare patients to access FDA-authorized breakthrough medical technology.
Resource / Emerging Policy Response Resources / Government & Legislative Affairs / Tariffs
Scott Whitaker Op-Ed: Medtech is vital to a healthier America
August 12, 2025
A powerful op-ed from AdvaMed’s CEO explaining why tariffs could undermine U.S. medtech innovation, jobs, and patient care—and what must be done.
News / Diagnostics / Digital Health / Government & Legislative Affairs / Medical Imaging / Regulatory Affairs
AdvaMed Welcomes MDUFA VI Discussion Kickoff at FDA Public Meeting
August 4, 2025
WASHINGTON, D.C.—AdvaMed, the medtech association, today welcomed the kickoff of the latest Medical Device User Fee Amendments (MDUFA) discussion at a public meeting at FDA headquarters. Three AdvaMed senior staff members encouraged the agency to build on the successes of the prior five such agreements to ensure the next agreement, MDUFA VI, delivers strong results for the American public.
News / Digital Health / Government & Legislative Affairs
AdvaMed Welcomes Administration’s Health Data Sharing Pledge
July 30, 2025
AdvaMed, the medtech association, released the following statement today from Shaye Mandle, executive director of the organization’s Digital Health Tech division, on the announcement from the White House, CMS, and HHS of a voluntary pledge by health care entities to make patient data more accessible and delivered faster between patients and providers.
News / Coverage & Payment / Diabetes / Diagnostics / Digital Health / Government & Legislative Affairs / Health Access
ICYMI: AdvaMed Op-ed on the Vital Role of Medtech in Making Americans Healthy Again
July 30, 2025
WASHINGTON, D.C. – In a new op-ed in The Washington Times, Scott Whitaker, president and CEO of AdvaMed, the Medtech Association, laid out medtech’s vital role in the Trump administration’s “Make America Healthy Again” initiative, calling for policies that ensure faster, broader access to lifesaving medtech.